Lymphocyte Activation Gene-3 Blocker drugs

1 medication in the FDA established pharmacologic class “Lymphocyte Activation Gene-3 Blocker”.

DrugTypeNDC products
Opdualag
nivolumab and relatlimab-rmbw
Rx1